KP-161 is an experimental antiviral drug being studied for the treatment of HIV/AIDS. It belongs to the class of nucleoside reverse transcriptase inhibitors. KP-1461 is a prodrug of the active antiviral agent KP-1212.
References
Wikipedia
KP-1461
Tags
- Anti-infective agent stubs
- Experimental drugs
- Prodrugs
- Reverse transcriptase inhibitors